Jun 4 |
Amphastar adds $50M to share buyback program
|
Jun 4 |
Amphastar Announces Additional $50 Million Increase to its Share Buyback Program
|
Jun 3 |
Amphastar Pharmaceuticals to Present at the Jefferies Global Healthcare Conference
|
May 30 |
Amphastar Pharmaceuticals: Buy When Fear Is Overblown
|
May 22 |
Amphastar Receives FDA Approval for Albuterol Sulfate Inhalation Aerosol
|
May 20 |
Amphastar Pharmaceuticals: Profitable Pharma With Strong Growth
|
May 16 |
Patent Peril: 3 Stocks at Risk From the FTC’s Drug Crusade
|
May 15 |
Reassessing Amphastar Pharmaceuticals
|
May 15 |
Implied Volatility Surging for Amphastar (AMPH) Stock Options
|
May 10 |
Amphastar Pharmaceuticals Reports Strong First Quarter Earnings, Surpassing Analyst Revenue ...
|